dantrolene has been researched along with Leg Length Inequality in 1 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
Leg Length Inequality: A condition in which one of a pair of legs fails to grow as long as the other, which could result from injury or surgery.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muiños, PA | 1 |
| Ortells, MA | 1 |
| Sánchez, G | 1 |
| Carrasco, MS | 1 |
1 other study available for dantrolene and Leg Length Inequality
| Article | Year |
|---|---|
[A case of malignant hyperthermia without hyperthermia].
Topics: Adolescent; Carbon Dioxide; Creatine Kinase; Dantrolene; Drug Eruptions; Fasciculation; Female; Huma | 1995 |